Exploring Advancements Together

2022 Tri-State Hematology Meeting—Updates from ASH ®

REGISTER NOW! This program brings Hematology Oncology research and clinical practice together to explore advancements presented at the 63rd Annual ASH® Meeting.
The Annual Meeting of the American Society of Hematology is the preeminent medical forum for the dissemination of information regarding the latest scientific advances in the diagnoses and treatment of hematological malignancies. Many community-based hematologists are unable to attend owing to patient or practice commitments. The scale of the Annual ASH® Meeting also limits the ability of attendees to interact with expert faculty (reducing for some hematologists the perceived value of the conference).

The 2022 Tri-State ASH® Update will bring national experts in Hematology Oncology research and clinical practice together with community-based practitioners, virtually, to explore the advancements presented at the 63rd ASH® Annual Meeting and Exposition.

The Jewish Hospital-Mercy Health Fegelman Auditorium; 4777 E. Galbraith Rd, Cincinnati, OH 45236. Free parking is available in front of the Education Building, in the parking deck adjacent to the hospital and the parking lot across from Entrance B beside the Education Building.


Elias Anaissie, MD
Medical Director
CTI Clinical Trial & Consulting


James H. Essell, MD
Medical Oncology/Hematology, OHC
Medical Director, Blood Cancer Center at The Jewish Hospital- Mercy Health


Presenting Sponsor: Live meeting Fegelman Auditorium 11:30am – 12:30pm
Premier Sponsor: Virtual meeting 11:30am – 12:30pm
Platinum Sponsor: Virtual meeting 2:00pm – 2:30pm
Gold Sponsors: Virtual meeting 2:30pm – 3:00pm


Presenting and Premier Sponsor

Platinum Sponsor

Gold Sponsor

Silver Sponsor

Educational Grant Supporters
  • Pharmacyclics
  • Jazz
  • AstraZeneca
Exhibitor Display Supporters
  • Abbvie
  • CTI Bio
  • Amgen
  • Novartis
  • Epizyme
  • Pfizer
  • Bristol, Myers, Squibb
  • Morphosys
  • Bristol, Myers, Squibb
  • Morphosys
  • Astellas
  • Johnson and Johnson
  • Genentech
  • Kite
  • Jazz
  • Alnylam

The Jewish Hospital is accredited by the OSMA as a provider of Physician Continuing Medical Education. The Jewish Hospital designates this live activity for a maximum of 4.0/hours of category 1 credit towards the AMA Physician’s Recognition Award. Each participant should claim only those hours of credit that he/she actually spent in the educational activity. The Jewish Hospital is an approved provider of continuing nursing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

All virtual/live education sessions must be attended in order to receive full 4.0 hours of CME credit. Certificates for virtual attendees will be emailed to the address listed under registration information.

7:30 a.m. – 8:00 a.m.

Check-in / Breakfast

8:00 a.m. – 08:10 a.m.

Welcome and Introductions

Elias Anaissie, M.D.

Medical Director CTI Clinical Trial & Consulting; Program Director

8:10 a.m. – 8:40 a.m.

AML and ALL: State of the Art in 2022

Hagop M. Kantarjian, MD

8:40 a.m. – 9:10 a.m.

CML, MDS, MPNs: State of the Art in 2022

Hagop M. Kantarjian, MD

9:10 a.m. – 9:25 a.m.

Break / Virtual & Live Exhibitor Hall

9:25 a.m. – 9:55 a.m.

Update on Novel therapies for Hodgkin Lymphoma and Aggressive Non-

Loretta Nastoupil, MD

9:55 a.m. – 10:25 a.m.

Sequencing Therapy options for patients with Indolent NHL and CLL/SLL.

Loretta Nastoupil, MD

10:25 a.m.– 11:25 a.m.

Immunotherapy for Multiple Myeloma

Nina Shah, MD

11:30 a.m. – 12:30 p.m.


12:30 p.m. – 1:00 p.m.

Optimal induction therapy for newly diagnosed MM

Sagar Lonial, MD

1:00 p.m. – 1:30 p.m.

Management of relapsed and refractory MM

Sagar Lonial, MD

1:30 p.m. – 1:45 p.m.


James Essell, M.D.

Medical Director Cincinnati Cancer and Cellular Therapy Center; Program Co-Director

Session Speakers

Hagop M. Kantarjian, MD

Professor and Chair | Department of Leukemia | MD Anderson Cancer Center

Sagar Lonial, MD FACP

Professor and Chair | Department of Hematology and Medical Oncology | Chief Medical Officer | Winship Cancer Institute | Emory University School of Medicine | Atlanta, Georgia

Loretta Nastoupil, MD

Associate Professor and Section Chief Indolent Lymphoma | Department of Lymphoma/Myeloma | Division of Cancer Medicine | MD Anderson Cancer Center

Nina Shah, MD

Professor of Clinical Medicine | Division of Hematology-Oncology | University of California, San Fransisco


Dr. Soumit Basu

Board-Certified Internist & Hematologist.

Emily Curran, MD

Assistant Professor

Saulius K Girnius, MD

Hematology Medical Oncology

James H. Essell, MD

Medical Oncologist, Hematologist and Transplant Specialist

Sponsorship Speakers

Presenting Level

Asad Dean

MD- Fellowship training University of Southwestern Medical Center at Dallas (Hematology/Oncology); Assistant Professor 2003-2006; Private Practice 2006-Current Texas Oncology, Fort Worth

Premier Level

Ralph V. Boccia, MD

Platinum Level

Dr. Edward Faber

Gold Level


Cyrus Khan, MD

Western Pennsylvania Hospital


Saulius K Girnius, MD

Hematology Medical Oncology


Anjen Chenn, MD, PhD

Medical Director, Research Triangle Park
Discipline Director, Molecular Oncology

  • Attending Physicians: $75.00
  • Industry and Exhibitors: $75.00
  • Residents and Fellows: $35.00
  • Advanced Practice Providers: $35.00
  • Pharmacists: $75.00
  • Nurses: $35.00
  • Allied Health Professionals: $35.00